# Agilis Robotics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/agilis-robotics

- Industry: Medical Devices & Equipment
- Headquarters: Guangzhou, China
- Website: www.agilisrobotics.com
- Total disclosed funding: $6M
- Latest round: Series A (Jun 28, 2022)
- Investors on record: 2

## About

Based in Shenzhen, China, and founded in 2021, Agilis Robotics is a medical company that focuses on the development of surgical robots. It is incubated by the University of Hong Kong. Jiaming Xu, the co-founder of the company, used to work in JL Play as chief investment adviser. In August 2021, the company raised CNY 10 million in angel funding. In March 2024, Agilis Robotics raised a series A+ funding for USD 10 million.

The company's main product is a robot system for endoscopic diagnosis and treatment, the surgical system includes surgical manipulators, host, and control systems. The surgical robot system can be applied to different human organs in the future, including the upper abdomen, lower abdomen, bladder, and urethra. Products can be used for examination or surgery of the digestive system, colon bladder system, and related fields.

## Funding rounds

- Series A, Jun 28, 2022, $6M — Korea Investment Partners, K2VC

## Investors

- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series A
- K2VC (https://capitalatlas.ai/funds/k2vc) — Series A